Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
8.67
-2.05 (-19.12%)
At close: Jun 26, 2026, 4:00 PM EDT
8.65
-0.02 (-0.23%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Omeros Employees
Omeros had 175 employees as of December 31, 2025. The number of employees decreased by 27 or -13.37% compared to the previous year.
Employees
175
Change (1Y)
-27
Growth (1Y)
-13.37%
Revenue / Employee
$56,531
Profits / Employee
$492,400
Market Cap
627.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| 4D Molecular Therapeutics | 196 |
| CorMedix | 191 |
| Prime Medicine | 146 |
| BridgeBio Oncology Therapeutics | 106 |
| SpyGlass Pharma | 68 |
| AgomAb Therapeutics NV | 62 |
| Faeth Therapeutics | 29 |
OMER News
- 14 hours ago - Omeros stock crashes on regulatory setback: buy the dip? - Invezz
- 16 hours ago - Omeros price target lowered to $33 from $40 at H.C. Wainwright - TheFly
- 19 hours ago - Omeros announces CHMP adopts negative opinion on MAA for narsoplimab - TheFly
- 19 hours ago - Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA - Business Wire
- 8 days ago - Omeros Transcript: AGM 2026 - Transcripts
- 11 days ago - Omeros Announces Webcast Details for Annual Meeting of Shareholders - Business Wire
- 14 days ago - Omeros trading resumes - TheFly
- 14 days ago - Omeros trading halted, volatility trading pause - TheFly